New All-Covering Herpes Zoster (Shingles) and Other Diseases Pipeline Reviews Recently Published by MarketPublishers.com03 Oct 2011 • by Natalie Aster
LONDON – New market research report “Herpes Zoster (Shingles) - Pipeline Review, H2 2011” provided by Global Markets Direct features detailed all-covering information on the market for Herpes Zoster (Shingles) – its therapeutic development, the latest updates, special features on late-stage and current projects.
Scope of the report:
- snapshot of the global therapeutic scenario for Herpes Zoster (Shingles);
- review of the Herpes Zoster (Shingles) products under development;
- coverage of products based on various stages of development ranging from discovery till registration stages;
- examination of pipeline projects on the basis of monotherapy and combined therapeutics;
- details on the Herpes Zoster (Shingles) pipeline on the basis of route of administration and molecule type;
- profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress;
- key discontinued pipeline projects information;
- latest news and deals relating to the products.
Title: Herpes Zoster (Shingles) - Pipeline Review, H2 2011
Published: September, 2011
Price: US$ 500
More pipeline reviews are also available including:
- Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2011
- Gouty Arthritis (Gout) - Pipeline Review, H2 2011
- Influenza A Infections - Pipeline Review, H2 2011
- Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2011
More new market reports by the publisher can be found at Global Markets Direct page.
The Market Publishers, Ltd.
Mrs. Tanya Rezler
Tel: +44 208 123 2220
Fax: +44 207 900 3970